Why is PRGO down?
Down 55% over five years while the S&P 500 rose 72%; up 30% in the past year.
- Its loss grew from $171.8M in fiscal 2024 to $1.43B in fiscal 2025.
PRGO's Quality Score fell 1 point on Tue, Nov 10, to 6. It did not trade higher than the day before.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 55% over five years while the S&P 500 rose 72%; up 30% in the past year.
| The chart | Stronger than 90% of stocks |
| Latest filing | 8-K, Nov 4 |
Fri Nov 27: Ex-dividend, $0.29 a shareAt the open. Pays Dec 15.
After its last 4 reports it closed +6.9% on average, higher 3 of 4 times.
Averagefor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
PRGO is #33 of 90 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 33 |
Net income over four quarters: PRGO -$1.77B, OGN $213M, PBH $155M, BHC -$841M.
Expected to report Thu Feb 25, before the open (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.0B, 5% less than a year ago; a loss of $0.20 a share, from a profit of $0.05.
“All In results were primarily driven by the same factors as Core net sales in addition to the year-over-year impact of divestitures and lower Infant Formula net sales.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Self Care | $613M | $577M | $633M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 4)
| Measure | Figure |
|---|---|
| Cash from operating activities as a percentage of adjusted net income | 60% |
Sales grew 0.8% a year over 5 years, fiscal 2020 to 2025.
Pays $1.16 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | -1.7% | +0.8% | +7.2% |
| Aug 5, 2026 | +17.1% | +23.1% | +19.2% |
| May 6, 2026 | +5.4% | +5.3% | -4.5% |
Sales grew in four of the last seven years, to $4.3B in 2025. It made a profit in two of the eight years.
RSI 65.9, MACD above signal, above both averages. Not scored.
Its dividends come to 96% of its free cash flow.
| Dividend | $1.16 a share a year |
| Paid out | About $162M a year |
| Free cash flow | $168M |
5 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: PRGO is under 0.1% of VYM and under 0.1% of VTI, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon.com, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
“The markets for our self-care products are highly competitive and differ for each product line, category and geographic region.”
PRGO scores 6 today, which Breakaway calls Average. It is #33 of 90 in Pharma by Quality Score, with 7 of 14 chart checks firing. Down 55% over five years while the S&P 500 rose 72%; up 30% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
PRGO scores 6 today, which Breakaway calls Average (6 to 10). That is #33 of 90 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind PRGO's 6.
Expected to report Thu Feb 25, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. PRGO closed higher after 3 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.